Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction-Reference-Cited by-同舟云学术

Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction

Published:2013-05 Issue:18 Volume:61 Page:1853-1859
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Mega Jessica L.,Braunwald Eugene,Murphy Sabina A.,Plotnikov Alexei N.,Burton Paul,Kiss Robert Gabor,Parkhomenko Alexander,Tendera Michal,Widimsky Petr,Gibson C. Michael

Funder

Johnson & Johnson Pharmaceutical Research and Development

Bayer Healthcare

Johnson & Johnson

Bristol-Myers Squibb/sanofi-aventis

Daiichi Sankyo

Eli Lilly

Abbott

AstraZeneca

Amgen

Bristol-Myers Squibb

GlaxoSmithKline

Merck

Pfizer

Roche

sanofi-aventis

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference8 articles.

1. Heart disease and stroke statistics--2012 update: a report from the American Heart Association;Roger;Circulation,2012

2. A tale of coronary artery disease and myocardial infarction;Nabel;N Engl J Med,2012

3. Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry;Fox;Nat Clin Pract Cardiovasc Med,2008

4. Rationale and design of the Anti-Xa Therapy to Lower cardiovascular events in Addition to standard therapy in Subjects with Acute Coronary Syndrome–Thrombolysis in Myocardial Infarction 51 (ATLAS-ACS 2 TIMI 51) trial: A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome

5. Rivaroxaban in patients with a recent acute coronary syndrome;Mega;N Engl J Med,2012

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis;Cochrane Database of Systematic Reviews;2024-01-24

2. Rationale and design of the direct oral anticoagulants for prevention of left ventricular thrombus after anterior acute myocardial infarction (APERITIF) trial;American Heart Journal;2023-12

3. Oral Anticoagulation in Patients With Advanced Chronic Kidney Disease and Atrial Fibrillation: Beyond Anticoagulation;Mayo Clinic Proceedings;2023-05

4. Dual pathway inhibition for atherosclerotic cardiovascular disease: Recent advances;Kardiologia Polska;2022-12-30

5. Rivaroxaban in heart failure patients with left ventricular thrombus: A retrospective study;Frontiers in Pharmacology;2022-10-07